Ilona Hagelstein
-
- Immune Cell Function and Interaction 14
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 6
-
- CAR-T cell therapy research 19
- Cancer Immunotherapy and Biomarkers 5
-
- Acute Myeloid Leukemia Research 4
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Helmut R. SalihGundram JungMelanie MärklinKathrin RothfelderJonas S. HeitmannMalte RoerdenClemens HinterleitnerLatifa Zekri
- Cited by
- ImmunologyOncologyHematology
- Journals
- Frontiers in Immunology (5 papers)International Journal of Molecular Sciences (2 papers)Annals of Hematology (2 papers)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Ilona Hagelstein
21 papers receiving 224 citations
Peers
Comparison fields: 5 of 31
- Immunology 157
- Oncology 150
- Hematology 33
- Radiology, Nuclear Medicine and Imaging 29
- Cancer Research 17
Countries citing papers authored by Ilona Hagelstein
This map shows the geographic impact of Ilona Hagelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilona Hagelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilona Hagelstein more than expected).
Fields of papers citing papers by Ilona Hagelstein
This network shows the impact of papers produced by Ilona Hagelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilona Hagelstein. The network helps show where Ilona Hagelstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ilona Hagelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 27 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2021 | 10 | |
| 16 | 2020 | 4 | |
| 17 | 2020 | 19 | |
| 18 | 2019 | 35 | |
| 19 | 2018 | 46 | |
| 20 | 2018 | 14 |
About Ilona Hagelstein
Ilona Hagelstein is a scholar working on Immunology, Oncology and Hematology, having authored 26 papers that have together received 224 indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), T-cell and B-cell Immunology (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (157 citations), Oncology (150 citations) and Hematology (33 citations). Ilona Hagelstein has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Helmut R. Salih, Gundram Jung, Melanie Märklin, Kathrin Rothfelder, Jonas S. Heitmann, Malte Roerden, Clemens Hinterleitner, Latifa Zekri, Tina Nuebling and Daniela Dörfel. Their work appears in journals such as Frontiers in Immunology, International Journal of Molecular Sciences, Annals of Hematology, Journal of Translational Medicine and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.